From 26th February, the medical cannabis division of Rokshaw Ltd is rebranding to Curaleaf Laboratories. Since its inception in 2012
High-quality cannabis on the medical market is the holy grail among both patients and clinics with heart. There’s still a
Written by Michael Sassano, CEO, Somai Pharmaceuticals Recently, I have become more optimistic about the global landscape of medical cannabis and the
The Script Assist app has launched a brand new ‘Find a Doctor’ feature – revolutionising the patient journey by enabling patients to
Spain’s Ministry of Health has launched a public consultation on its proposals for a medical cannabis framework in the country.
Germany’s highly anticipated CanG bill is now finally set to have its final reading in the Bundestag this week following
In the fast-paced and ever-evolving European cannabis industry, the scramble for top-tier talent is intensifying. Companies across the spectrum, from
The Irish Government has approved the establishment of an Oireachtas committee to examine the Citizens’ Assembly recommendations for the decriminalisation
MGC Pharmaceuticals / Argent BioPharma MGC Pharmaceuticals has become the latest UK-listed cannabis company to opt for a rebrand
Bedrocan, which for years has only supported external researchers financially, today announced the launching of its own Clinical Research Unit
We won’t spam you
© 2024 Prohibition Holdings Ltd. All Rights Reserved.
© 2023 Prohibition Holdings Ltd. All Rights Reserved.